tradingkey.logo
tradingkey.logo
Search

Beigene Says Pharmacyclics Litigation Is Not Expected To Affect Operation

ReutersApr 30, 2025 12:23 AM
facebooktwitterlinkedin
View all comments0

- Beigene 688235.SS:

  • SAYS PHARMACYCLICS LITIGATION IS NOT HAVING ADVERSE EFFECT ON DEVELOPMENT, SALES OF BRUKINSA IN U.S.

  • SAYS PHARMACYCLICS LITIGATION IS NOT EXPECTED TO HAVE companyADVERSE EFFECT ON CO'S PRODUCTION, OPERATION

Source text

Further company coverage: 688235.SS

Disclaimer: The information provided on this website is for educational and informational purposes only and should not be considered financial or investment advice.

Comments (0)

Click the $ button, enter the symbol, and select to link a stock, ETF, or other ticker.

0/500
Commenting Guidelines
Loading...

Recommended Articles

Tradingkey
KeyAI